|
WH-4-023
Chemical Information
M.Wt
568.67
Storage
Please store the product under the reco...
更多>>
|
|
|
PP1
Chemical Information
M.Wt
281.36
Storage
Please store the product under the reco...
更多>>
|
|
|
PP2
Chemical Information
M.Wt
301.77
Storage
Please store the product under the reco...
更多>>
|
|
|
Imatinib
Description of:Imatinib
Imatinib (originally STI571) is a drug used to treat certain cancers. It is marketed by Novartis as Gleevec (USA) or Gl...
更多>>
|
|
|
Dasatinib
Theoretical analysis:Dasatinib
Molecular Formula: C22H28ClN7O3S
Formula Weight: 506.02082
CAS No.: 863127-77-9
A...
更多>>
|
|
|
Bafetinib(INNO-406)
Description of:Bafetinib(INNO-406)
Bafetinib (INNO-406) is an orally available, dual Abl/Lyn kinase inhibitor that is up to 55-times more poten...
更多>>
|
|
|
PCI-32765
Description of:PCI-32765
PCI-32765 is highly active and well tolerated in CLL/SLL pts irrespective of high risk genomic abnormalities. Although...
更多>>
|
|
|
Bafetinib
Description of:Bafetinib
Bafetinib (INNO-406) is an orally available, dual Abl/Lyn kinase inhibitor (cell IC50 : 11 ~ 22 nM).
Theoreti...
更多>>
|
|
|
Fingolimod(FTY720)
Description of:Fingolimod(FTY720)
Fingolimod is Src-bcr-Abl Inhibitor & S1P receptor agonist with IC50 of 0.137, 10.98 nM for (S)- and (R)-...
更多>>
|
|
|
Saracatinib
Description of:Saracatinib
AZD0530 inhibited tumor growth in a manner independent of dose and inhibited phosphorylation of Focal adhesion kinas...
更多>>
|
|